Consultant Orthopaedic Surgeon and Honorary Senior Lecturer
North of England Bone and Soft Tissue Tumour Service, Newcastle upon Tyne Hospitals NHS Foundation Trust and Translational and Clinical Research Institute, Newcastle University, UK, United Kingdom
Dr Kenneth Rankin graduated in 1999 from the University of Dundee. His basic surgical training was in Newcastle followed by an MD investigating the cellular biology of bone metastases. Mr Rankin completed his higher specialist training in Perth and Dundee followed by a return to the North East as NIHR Academic Clinical Lecturer.
His current post as Consultant Orthopaedic Surgeon and Honorary Senior Lecturer is comprised mainly of orthopaedic oncology including the surgical management of bone and soft tissue sarcomas and metastatic bone disease. He also carries out hip and knee replacements for arthritis.
As a Clinician Scientist Dr Rankin has developed an international reputation for translational research for the detection of circulating tumour cells in sarcoma patients and carried out the world’s first case series of fluorescence guided surgery in sarcoma.
Working in close collaboration with scientists at Newcastle University, he leads on basic and translational sarcoma research at the Newcastle Centre for Cancer. He is the Chief Investigator for the NIHR £1.45 million ($1.5 million) SarcoSIGHT fluorescence guided surgery randomised surgical trial.